3:44 PM · 10 September 2020

Quest Diagnostics stock is rising on upbeat guidance

Quest
Stocks
DGX.US, Quest Diagnostics Inc
-
-
Quest Diagnostics (DGX.US) stock rose over 3% after the medical lab operator lifted its full-year guidance and profit outlook, citing a faster-than-anticipated recovery in testing volumes through the end of August. Company now expects adjusted earnings of $7.42 to $8.92 per share, up from the prior range of $5.66 to $7.66 a share. The current consensus estimate is $8.51 a share. The company raised its 2020 guidance range for revenue to $8.4 billion to $8.8 billion from $8.0 billion to $8.6 billion, compared with the FactSet consensus of $8.69 billion.
Quest Diagnostics (DGX.US) - stock managed to bounce off the 200 MA (red line) and rally. Should upbeat moods prevail, resistance at $119 may come into play. This level is also additionally strengthened by 50 MA (green line). However, should market sentiment change, the nearest support is located at $104.00. Source: xStation5
15 October 2025, 5:10 PM

TSMC Earnings Preview: Will the Key Semiconductor Supplier Surprise the Market?

15 October 2025, 3:05 PM

US Open: American Indices Rally on Anticipated End of Fed Balance Sheet Reduction

15 October 2025, 2:53 PM

Bank of America, Wells Fargo, and Morgan Stanley: Q3 2025 Earnings Overview

15 October 2025, 1:24 PM

Abbott reports no surprises in Q3, but tariff risks and lowered forecasts drag the share price down💡

Join over 1 700 000 XTB Group Clients from around the world

The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissão de Valores Mobiliários (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits